A Glucuronide Control Tested a Step That a Free Cannabinoid Spike Could Miss
The neonatal-matrix study used a glucuronide-containing quality-control sample to evaluate hydrolysis. A control containing only free metabolite would not challenge that conversion step in the same way.
The control was designed around sample preparation
The methods included a high control containing the conjugated carboxy metabolite, with the free form excluded from that control. The researchers adjusted the spike for molecular-mass differences when evaluating hydrolysis efficiency. Their abbreviation THCA referred to the carboxy metabolite, not plant tetrahydrocannabinolic acid.
Hydrolysis and extraction answer different questions
A method might recover free analyte efficiently but incompletely release it from a conjugate. A free-analyte control could therefore perform well while leaving an important preparation step insufficiently tested. The conjugated control adds evidence about that specific part of the workflow.
Preserve what the reported concentration represents
The result after hydrolysis cannot automatically be treated as the original unconjugated concentration in the specimen. Matrix and preparation remain relevant to comparisons between meconium, cord tissue and other tests. This control strategy concerns analytical performance, not fetal dose or developmental harm. It illustrates why a validation sample should challenge the transformation on which the eventual reported analyte depends.
Related analysis: the study’s broader findings and limitations.
